Pharmafile Logo
Pharmafocus logo
Advanced Search

Rentschler Biopharma

Showing 1 posts of 1 posts found.

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026
Rentschler Biopharma, interim CEO

Rentschler Biopharma, a contract development and manufacturing organisation (CDMO) specialising in biopharmaceutical products, has announced the appointment of Uwe Buecheler …

Appointment
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026